MedPass International

What MedPass International does

MedPass International is a Paris-based, privately held professional services firm founded in 1991 that provides clinical development and market access support to clients commercializing emerging medical technologies. With a headcount of 11-50 employees, the firm operates in a niche consultancy capacity focused on helping medical technology innovators navigate clinical and regulatory pathways and reach commercial markets.

The firm's business model and specific service lines are not detailed in the available data, and no customer logos, partnership agreements, product launches, or management team disclosures are present. There is no information on revenue model, pricing structure, or go-to-market motion. The firm does not have any disclosed proprietary technology, certifications, patents, or AI/ML capabilities.

A critical operational signal is that the company's stated web domain, medpass.org, is currently listed for sale on Spaceship.com with no active corporate website. This, combined with the complete absence of recent funding, hiring, product, or partnership signals, indicates the firm is either dormant, in wind-down, or has significantly diminished operational activity despite its founding date of 1991.

Name

MedPass International

Website

https://medpass.org

Company type

Private

Founded year

1991

Headcount range

11–50 employees

Short description

MedPass International is a Paris-based private firm founded in 1991 that provides clinical development and market access services to clients commercializing emerging medical technologies. The firm employs 11-50 people; its domain is currently listed for sale.

Ownership category

akta.pro rank

Headquarters

HQ city

Paris

HQ country

France

HQ region

Europe

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales

Core offering

MedPass International provides clients with clinical development and market access services for emerging medical technologies. The firm supports medical device and healthcare technology companies in navigating clinical development pathways and achieving market entry for their products.

Differentiator

Problem solved

Functional benefit

Products and services

• Clinical Development Services Support for clients developing emerging medical technologies through clinical development pathways. Designed for medical device and healthcare technology companies needing specialized clinical development expertise.
• Market Access Services Assistance for medical technology clients in gaining market access for their emerging medical technology products. Designed for medical device and healthcare technology companies seeking to enter or expand in target markets.

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Recent moves1 record

Expansion highlights1 record

Broad incumbents

• IQVIA: IQVIA is a global life sciences services and clinical research firm with extensive regulatory and market access capabilities, representing the scaled incumbent alternative to specialty firms like MedPass International.
• ICON plc: ICON is a large global CRO with dedicated medical device and clinical development service lines, serving as a broad incumbent that competes with boutique firms like MedPass International for clinical and market access engagements.
• WuXi AppTec: WuXi AppTec is a large global CRO/CDMO with clinical and regulatory service lines supporting medical technology sponsors, representing a scaled incumbent benchmark against which a boutique like MedPass International would compete.
• Charles River Laboratories: Charles River Laboratories provides clinical and preclinical research services including support for medical device sponsors, operating as a broad incumbent competing for the same clinical development engagements MedPass International targets.
• Parexel International: Parexel is a global CRO with regulatory, clinical, and market access service offerings that overlap with the boutique clinical development and market access niche MedPass International occupies.

Direct peers

• NAMSA: NAMSA is a medical device-focused contract research organization offering clinical development, regulatory, and market access services — directly comparable to MedPass International's stated clinical development and market access remit for emerging medical technologies.
• RQM+: RQM+ is a regulatory and quality consulting firm focused on medical devices and in vitro diagnostics, providing clinical, regulatory, and market access support — directly comparable in service mix to MedPass International's positioning.
• Eurofins Medical Device Services: Eurofins Medical Device Services provides testing, regulatory, and clinical support to medical device manufacturers across Europe, overlapping directly with MedPass International's stated clinical development and market access remit.

Regional players

• TÜV SÜD: TÜV SÜD operates EU notified body services and adjacent clinical/regulatory support for medical device manufacturers, making it a Europe-centric peer relevant to MedPass International's Paris-based EU market access positioning.
• BSI Group: BSI is a notified body providing CE marking and regulatory support for medical devices in Europe — a comparable regulatory services counterpart for any EU-focused clinical development and market access firm.

Market position

Strengths3 records

Weaknesses4 records

Competitive moat2 records

Key risks5 records

Key highlights3 records

Customer concentration

• LinkedInlinkedin.com/company/medpass-international

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MedPass International